Veranex Preclinical Services, France (Formerly known as IMMR)

Veranex brings together best-in-class expertise in product design and engineering, medical device evaluation, clinical development, data management, regulatory, and market access to deliver an integrated and comprehensive solution from concept to commercial success. Headquartered in Paris, Veranex Preclincal Services, France (formerly known as IMMR) is a world-class, market leader in the design and conduct of MedTech and Biotech preclinical studies in large models. Its in-house expertise and state-of-the-art, FDA, OECD GLP-inspected and AAALAC International-accredited facilities are unparalleled for successfully completing sophisticated studies with novel interventional or surgical technologies. While we are perhaps most well-known for our world-leading expertise in complex...

Early research and development studies,good laboratory practice compliant studies,surgical and physician training,histopathology of explanted soft and hard tissue,chronic and acute studies,fda & ce mark process,confidentialy procedures,implantation,medical imaging,preclinical model development,regulatory consulting,interventional cardiology,catheter-based approaches,orthopedics,cardiac surgery,neuro-surgery,tavi,tmvr,mitral regurgitation,ttvr,comparative anatomy,cardiovascular and neurovascular expertise,biotechnology,innovation,robotics,dentistry,urology,fetal surgery,ophtalmology,medical devices,and tricuspid valve regurgitation

Veranex preclinical services, france (formerly known as immr) operates in the Research services industry.

Veranex preclinical services, france (formerly known as immr)'s revenue is 11m - 100m

Veranex preclinical services, france (formerly known as immr) has 11 - 50 employees.